Literature DB >> 8557376

Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide.

S S Kaplan1, J R Lancaster, R E Basford, R L Simmons.   

Abstract

The role of reactive nitrogen intermediates (RNI) such as nitric oxide (.NO) in host defense against pyogenic microorganisms is unclear, and the actual interactive effect of RNI and reactive oxidative intermediates (ROI) for microbial killing has not been determined. Since, in nature, ROI and RNI might be generated together within any local infection, we evaluated the separate and interactive effects of .NO and O2- on staphylococcal survival by using a simplified system devoid of eukaryotic cells. These studies showed that prolonged exposure of staphylococci to .NO does not result in early loss of viability but instead is associated with a dose-related delayed loss of viability. This effect is abrogated by the presence of hemoglobin, providing further evidence that the effect is RNI associated. Superoxide-mediated killing also is dose related, but in contrast to RNI-mediated killing, it is rapid and occurs within 2 h of exposure. We further show that the interaction of .NO and O(2)- results in decreased O(2)--mediated staphylococcal killing at early time points. .NO, however, appears to enhance or stabilize microbial killing over prolonged periods of incubation. This study did not produce evidence of early synergism of ROI and RNI, but it does suggest that .NO may contribute to host defense, especially when ROI-mediated killing is compromised.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557376      PMCID: PMC173729          DOI: 10.1128/iai.64.1.69-76.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

Review 2.  Pathological implications of nitric oxide, superoxide and peroxynitrite formation.

Authors:  J S Beckman; J P Crow
Journal:  Biochem Soc Trans       Date:  1993-05       Impact factor: 5.407

3.  Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes.

Authors:  M Schneemann; G Schoedon; S Hofer; N Blau; L Guerrero; A Schaffner
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

4.  Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro.

Authors:  S N Belenky; R A Robbins; I Rubinstein
Journal:  J Leukoc Biol       Date:  1993-05       Impact factor: 4.962

5.  Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism.

Authors:  M A Muñoz-Fernández; M A Fernández; M Fresno
Journal:  Immunol Lett       Date:  1992-06       Impact factor: 3.685

6.  Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.

Authors:  S N Belenky; R A Robbins; S I Rennard; G L Gossman; K J Nelson; I Rubinstein
Journal:  J Lab Clin Med       Date:  1993-10

7.  Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species.

Authors:  D A Wink; I Hanbauer; M C Krishna; W DeGraff; J Gamson; J B Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions.

Authors:  E Moilanen; P Vuorinen; H Kankaanranta; T Metsä-Ketelä; H Vapaatalo
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

9.  Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication.

Authors:  K D Croen
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  The reaction of no with superoxide.

Authors:  R E Huie; S Padmaja
Journal:  Free Radic Res Commun       Date:  1993
View more
  19 in total

Review 1.  Nitric oxide and redox mechanisms in the immune response.

Authors:  David A Wink; Harry B Hines; Robert Y S Cheng; Christopher H Switzer; Wilmarie Flores-Santana; Michael P Vitek; Lisa A Ridnour; Carol A Colton
Journal:  J Leukoc Biol       Date:  2011-01-13       Impact factor: 4.962

Review 2.  Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity.

Authors:  F C Fang
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 3.  Macrophages in resistance to candidiasis.

Authors:  A Vázquez-Torres; E Balish
Journal:  Microbiol Mol Biol Rev       Date:  1997-06       Impact factor: 11.056

4.  Expression of CXCR1 (interleukin-8 receptor) in murine macrophages after staphylococcus aureus infection and its possible implication on intracellular survival correlating with cytokines and bacterial anti-oxidant enzymes.

Authors:  Biswadev Bishayi; Debasish Bandyopadhyay; Arnab Majhi; Rana Adhikary
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

5.  Role of Salmonella surface components in immunomodulation of inflammatory mediators.

Authors:  Alka Choudhary; Ram Prakash Tiwari; Ashwani Koul; Vishal Chanana; Saraswati Gupta; Praveen Rishi
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

6.  Interaction of Bartonella henselae with the murine macrophage cell line J774: infection and proinflammatory response.

Authors:  T Musso; R Badolato; D Ravarino; S Stornello; P Panzanelli; C Merlino; D Savoia; R Cavallo; A N Ponzi; M Zucca
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

7.  The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A.

Authors:  Philip O'Reilly; Judy M Hickman-Davis; Philip McArdle; K Randall Young; Sadis Matalon
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

8.  Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxides.

Authors:  R Phillips; O Adjei; S Lucas; N Benjamin; M Wansbrough-Jones
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

9.  In vitro evaluation of a new treatment for urinary tract infections caused by nitrate-reducing bacteria.

Authors:  S Carlsson; M Govoni; N P Wiklund; E Weitzberg; J O Lundberg
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

10.  Inhibition of staphylococcal biofilm formation by nitrite.

Authors:  Steffen Schlag; Christiane Nerz; Timo A Birkenstock; Florian Altenberend; Friedrich Götz
Journal:  J Bacteriol       Date:  2007-08-24       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.